S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as grain leaves Ukraine; plant hit
NASDAQ:SGRY

Surgery Partners - SGRY Stock Forecast, Price & News

$36.90
+0.89 (+2.47%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.09
$37.87
50-Day Range
$27.55
$40.30
52-Week Range
$26.66
$63.87
Volume
229,498 shs
Average Volume
530,647 shs
Market Capitalization
$3.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$58.67

Surgery Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
59.0% Upside
$58.67 Price Target
Short Interest
Bearish
10.71% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of Surgery Partners in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$1.05 M Sold Last Quarter
Proj. Earnings Growth
516.67%
From $0.06 to $0.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

801st out of 1,283 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks

SGRY stock logo

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Royal Bank of Canada dropped their price objective on shares of Surgery Partners from $65.00 to $62.00 and set an "outperform" rating on the stock in a research note on Wednesday. Citigroup lifted their target price on shares of Surgery Partners from $61.00 to $64.00 in a report on Wednesday, May 4th. StockNews.com cut shares of Surgery Partners from a "hold" rating to a "sell" rating in a report on Tuesday, July 26th. Bank of America cut shares of Surgery Partners from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $55.00 to $36.00 in a report on Wednesday, June 15th. Finally, Benchmark lifted their target price on shares of Surgery Partners from $65.00 to $72.00 in a report on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Surgery Partners presently has an average rating of "Hold" and a consensus target price of $58.67.

Surgery Partners Stock Up 2.5 %

SGRY opened at $36.90 on Friday. The company has a quick ratio of 1.61, a current ratio of 1.51 and a debt-to-equity ratio of 1.48. The firm has a 50 day moving average price of $33.85 and a 200-day moving average price of $44.22. Surgery Partners has a twelve month low of $26.66 and a twelve month high of $63.87. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of -105.43, a PEG ratio of 12.99 and a beta of 2.87.

Insider Activity

In other news, insider George Goodwin sold 12,586 shares of the business's stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $40.00, for a total transaction of $503,440.00. Following the completion of the transaction, the insider now directly owns 31,806 shares of the company's stock, valued at $1,272,240. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 26,380 shares of company stock valued at $1,053,599 over the last three months. Insiders own 3.30% of the company's stock.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

Surgery Partners (NASDAQ:SGRY) PT Lowered to $62.00
Recap: Surgery Partners Q2 Earnings
StockNews.com Lowers Surgery Partners (NASDAQ:SGRY) to Sell
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Company Calendar

Last Earnings
11/02/2021
Today
8/07/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
General medical & surgical hospitals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGRY
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$58.67
High Stock Price Forecast
$73.00
Low Stock Price Forecast
$36.00
Forecasted Upside/Downside
+59.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$-70,900,000.00
Pretax Margin
5.37%

Debt

Sales & Book Value

Annual Sales
$2.23 billion
Cash Flow
$1.02 per share
Book Value
$22.69 per share

Miscellaneous

Free Float
86,967,000
Market Cap
$3.32 billion
Optionable
Optionable
Beta
2.87














SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners
or view top-rated stocks.

What is Surgery Partners' stock price forecast for 2022?

7 Wall Street research analysts have issued 1-year target prices for Surgery Partners' stock. Their SGRY stock forecasts range from $36.00 to $73.00. On average, they anticipate Surgery Partners' share price to reach $58.67 in the next twelve months. This suggests a possible upside of 59.0% from the stock's current price.
View analysts' price targets for Surgery Partners
or view top-rated stocks among Wall Street analysts.

How has Surgery Partners' stock performed in 2022?

Surgery Partners' stock was trading at $53.41 at the beginning of the year. Since then, SGRY stock has decreased by 30.9% and is now trading at $36.90.
View the best growth stocks for 2022 here
.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our earnings forecast for Surgery Partners
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its earnings results on Tuesday, November, 2nd. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.04. The business earned $559.20 million during the quarter, compared to analyst estimates of $554.15 million. Surgery Partners had a negative net margin of 1.23% and a negative trailing twelve-month return on equity of 0.61%. During the same period last year, the firm earned ($0.59) earnings per share.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2022 earnings guidance on Tuesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.50 billion-$2.60 billion, compared to the consensus revenue estimate of $2.56 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners CEO Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among Surgery Partners' employees.

What other stocks do shareholders of Surgery Partners own?

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a variety of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (1.18%), Rheos Capital Works Inc. (0.19%), TD Asset Management Inc. (0.11%), Polianta Ltd (0.02%), Wolverine Asset Management LLC (0.02%) and Envestnet Asset Management Inc. (0.01%). Company insiders that own Surgery Partners stock include Anthony Taparo, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends for Surgery Partners
.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $36.90.

How much money does Surgery Partners make?

Surgery Partners (NASDAQ:SGRY) has a market capitalization of $3.32 billion and generates $2.23 billion in revenue each year. The company earns $-70,900,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis.

How many employees does Surgery Partners have?

Surgery Partners employs 10,900 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for Surgery Partners is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.